TSMHT
BIIB icon

Thurston Springer Miller Herd & Titak’s Biogen BIIB Stock Holding History

Thurston Springer Miller Herd & Titak’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.16K Hold
10
– – ﹤0.01% 1088
2026
Q1 		$1.83K Hold
10
– – ﹤0.01% 1187
2025
Q4 		$1.76K Buy
+10
New +$1.63K ﹤0.01% 1225

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Thurston Springer Miller Herd & Titak's BIIB Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak held its Biogen (BIIB) position steady in Q2 2026 at 10 shares worth $2.16K. The position accounts for ﹤0.01% of the portfolio, ranked #1088.

Thurston Springer Miller Herd & Titak first reported a position in BIIB in Q4 2025 and has held it in 3 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 10 shares of Biogen worth $2.16K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak left its Biogen share count unchanged in Q2 2026.
  • Biogen made up ﹤0.01% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #1088 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Biogen in Q4 2025 and has held it in 3 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.